Risedronate to Prevent Bone Loss After Sleeve Gastrectomy: Study Design and Feasibility Report of a Pilot Randomized Controlled Trial

Mounting evidence implicates bariatric surgery as a cause of increased skeletal fragility and fracture risk. Bisphosphonate therapy reduces osteoporotic fracture risk and may be effective in minimizing bone loss associated with bariatric surgery. The main objective of this pilot randomized controlle...

Descripción completa

Detalles Bibliográficos
Autores principales: Swafford, Ashlyn A, Ard, Jamy D, Beavers, Daniel P, Gearren, Peri C, Fernandez, Adolfo Z, Ford, Sherri A, Greene, Katelyn A, Kammire, Daniel E, Nesbit, Beverly A, Reed, Kylie K, Weaver, Ashley A, Beavers, Kristen M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574708/
https://www.ncbi.nlm.nih.gov/pubmed/33103032
http://dx.doi.org/10.1002/jbm4.10407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574708/
https://www.ncbi.nlm.nih.gov/pubmed/33103032
http://dx.doi.org/10.1002/jbm4.10407

Ejemplares similares